Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort
Abstract The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence ra...
Saved in:
| Published in | TH open : companion journal to thrombosis and haemostasis Vol. 2; no. 2; pp. e131 - e138 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Stuttgart · New York
Georg Thieme Verlag KG
01.04.2018
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2512-9465 2567-3459 2512-9465 |
| DOI | 10.1055/s-0038-1641678 |
Cover
| Abstract | Abstract
The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence rates (IRs) of VTE differed in patients who were alive at least 2 years after a cancer diagnosis without VTE compared with cancer-free references in a population-based cohort study. The study entry was 2 years after a first cancer diagnosis. For each cancer-exposed subject, five reference subjects were identified within the cohort. The IRs were calculated as number of VTEs per 1,000 person years (×10
−3
p-y) in total and in distinct cancer types and corresponding reference subjects. Incidence rate ratios (IRRs) were calculated by Poisson's regression. During a mean follow-up of 5.3 years, 110 VTEs occurred among the 7,288 cancer-exposed subjects and 321 VTEs occurred among the 36,297 identified reference subjects. The IR of VTE was higher for cancer-exposed subjects compared with reference subjects, IRs 3.7 × 10
−3
p-y, 95% CI: 3.1 to 4.5 and 1.9 × 10
−3
p-y, 95% CI: 1.7 to 2.2, respectively. IRs of VTE in most solid cancer types declined to almost the same level as in the reference subjects 2 years after cancer diagnosis, but remained higher in hematological cancers, IRR 4.0, 95% CI: 2.0 to 7.8. |
|---|---|
| AbstractList | The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence rates (IRs) of VTE differed in patients who were alive at least 2 years after a cancer diagnosis without VTE compared with cancer-free references in a population-based cohort study. The study entry was 2 years after a first cancer diagnosis. For each cancer-exposed subject, five reference subjects were identified within the cohort. The IRs were calculated as number of VTEs per 1,000 person years (×10−3 p-y) in total and in distinct cancer types and corresponding reference subjects. Incidence rate ratios (IRRs) were calculated by Poisson's regression. During a mean follow-up of 5.3 years, 110 VTEs occurred among the 7,288 cancer-exposed subjects and 321 VTEs occurred among the 36,297 identified reference subjects. The IR of VTE was higher for cancer-exposed subjects compared with reference subjects, IRs 3.7 × 10−3 p-y, 95% CI: 3.1 to 4.5 and 1.9 × 10−3 p-y, 95% CI: 1.7 to 2.2, respectively. IRs of VTE in most solid cancer types declined to almost the same level as in the reference subjects 2 years after cancer diagnosis, but remained higher in hematological cancers, IRR 4.0, 95% CI: 2.0 to 7.8. The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence rates (IRs) of VTE differed in patients who were alive at least 2 years after a cancer diagnosis without VTE compared with cancer-free references in a population-based cohort study. The study entry was 2 years after a first cancer diagnosis. For each cancer-exposed subject, five reference subjects were identified within the cohort. The IRs were calculated as number of VTEs per 1,000 person years (×10 −3 p-y) in total and in distinct cancer types and corresponding reference subjects. Incidence rate ratios (IRRs) were calculated by Poisson's regression. During a mean follow-up of 5.3 years, 110 VTEs occurred among the 7,288 cancer-exposed subjects and 321 VTEs occurred among the 36,297 identified reference subjects. The IR of VTE was higher for cancer-exposed subjects compared with reference subjects, IRs 3.7 × 10 −3 p-y, 95% CI: 3.1 to 4.5 and 1.9 × 10 −3 p-y, 95% CI: 1.7 to 2.2, respectively. IRs of VTE in most solid cancer types declined to almost the same level as in the reference subjects 2 years after cancer diagnosis, but remained higher in hematological cancers, IRR 4.0, 95% CI: 2.0 to 7.8. The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence rates (IRs) of VTE differed in patients who were alive at least 2 years after a cancer diagnosis without VTE compared with cancer-free references in a population-based cohort study. The study entry was 2 years after a first cancer diagnosis. For each cancer-exposed subject, five reference subjects were identified within the cohort. The IRs were calculated as number of VTEs per 1,000 person years (×10 -3 p-y) in total and in distinct cancer types and corresponding reference subjects. Incidence rate ratios (IRRs) were calculated by Poisson's regression. During a mean follow-up of 5.3 years, 110 VTEs occurred among the 7,288 cancer-exposed subjects and 321 VTEs occurred among the 36,297 identified reference subjects. The IR of VTE was higher for cancer-exposed subjects compared with reference subjects, IRs 3.7 × 10 -3 p-y, 95% CI: 3.1 to 4.5 and 1.9 × 10 -3 p-y, 95% CI: 1.7 to 2.2, respectively. IRs of VTE in most solid cancer types declined to almost the same level as in the reference subjects 2 years after cancer diagnosis, but remained higher in hematological cancers, IRR 4.0, 95% CI: 2.0 to 7.8.The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence rates (IRs) of VTE differed in patients who were alive at least 2 years after a cancer diagnosis without VTE compared with cancer-free references in a population-based cohort study. The study entry was 2 years after a first cancer diagnosis. For each cancer-exposed subject, five reference subjects were identified within the cohort. The IRs were calculated as number of VTEs per 1,000 person years (×10 -3 p-y) in total and in distinct cancer types and corresponding reference subjects. Incidence rate ratios (IRRs) were calculated by Poisson's regression. During a mean follow-up of 5.3 years, 110 VTEs occurred among the 7,288 cancer-exposed subjects and 321 VTEs occurred among the 36,297 identified reference subjects. The IR of VTE was higher for cancer-exposed subjects compared with reference subjects, IRs 3.7 × 10 -3 p-y, 95% CI: 3.1 to 4.5 and 1.9 × 10 -3 p-y, 95% CI: 1.7 to 2.2, respectively. IRs of VTE in most solid cancer types declined to almost the same level as in the reference subjects 2 years after cancer diagnosis, but remained higher in hematological cancers, IRR 4.0, 95% CI: 2.0 to 7.8. Abstract The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence rates (IRs) of VTE differed in patients who were alive at least 2 years after a cancer diagnosis without VTE compared with cancer-free references in a population-based cohort study. The study entry was 2 years after a first cancer diagnosis. For each cancer-exposed subject, five reference subjects were identified within the cohort. The IRs were calculated as number of VTEs per 1,000 person years (×10 −3 p-y) in total and in distinct cancer types and corresponding reference subjects. Incidence rate ratios (IRRs) were calculated by Poisson's regression. During a mean follow-up of 5.3 years, 110 VTEs occurred among the 7,288 cancer-exposed subjects and 321 VTEs occurred among the 36,297 identified reference subjects. The IR of VTE was higher for cancer-exposed subjects compared with reference subjects, IRs 3.7 × 10 −3 p-y, 95% CI: 3.1 to 4.5 and 1.9 × 10 −3 p-y, 95% CI: 1.7 to 2.2, respectively. IRs of VTE in most solid cancer types declined to almost the same level as in the reference subjects 2 years after cancer diagnosis, but remained higher in hematological cancers, IRR 4.0, 95% CI: 2.0 to 7.8. The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in comparison to a similar background population has been sparsely investigated. The aim of the study was to investigate if incidence rates (IRs) of VTE differed in patients who were alive at least 2 years after a cancer diagnosis without VTE compared with cancer-free references in a population-based cohort study. The study entry was 2 years after a first cancer diagnosis. For each cancer-exposed subject, five reference subjects were identified within the cohort. The IRs were calculated as number of VTEs per 1,000 person years (×10 p-y) in total and in distinct cancer types and corresponding reference subjects. Incidence rate ratios (IRRs) were calculated by Poisson's regression. During a mean follow-up of 5.3 years, 110 VTEs occurred among the 7,288 cancer-exposed subjects and 321 VTEs occurred among the 36,297 identified reference subjects. The IR of VTE was higher for cancer-exposed subjects compared with reference subjects, IRs 3.7 × 10 p-y, 95% CI: 3.1 to 4.5 and 1.9 × 10 p-y, 95% CI: 1.7 to 2.2, respectively. IRs of VTE in most solid cancer types declined to almost the same level as in the reference subjects 2 years after cancer diagnosis, but remained higher in hematological cancers, IRR 4.0, 95% CI: 2.0 to 7.8. |
| Author | Næss, Inger Anne Overvad, Kim Hammerstrøm, Jens Hindberg, Kristian Tjønneland, Anne Brækkan, Sigrid K. Cannegieter, Suzanne C. Gade, Inger Lise Rosendaal, Frits R. Severinsen, Marianne T. Gran, Olga V. Kristensen, Søren R. Hansen, John-Bjarne |
| AuthorAffiliation | 1 Department of Clinical Medicine, Aalborg University, Aalborg, Denmark 2 Department of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø—The Arctic University of Norway, Tromsø, Norway 5 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands 11 Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark 8 Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway 4 Department of Haematology, Trondheim University Hospital, Trondheim, Norway 6 Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark 3 Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway 10 Department of Haematology, Aalborg University Hospital, Aalborg, Denmark 7 Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark 9 Department of Diet, Genes and Environment, Danish Cancer Socie |
| AuthorAffiliation_xml | – name: 3 Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway – name: 7 Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark – name: 9 Department of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark – name: 6 Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark – name: 11 Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark – name: 2 Department of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø—The Arctic University of Norway, Tromsø, Norway – name: 10 Department of Haematology, Aalborg University Hospital, Aalborg, Denmark – name: 8 Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway – name: 1 Department of Clinical Medicine, Aalborg University, Aalborg, Denmark – name: 4 Department of Haematology, Trondheim University Hospital, Trondheim, Norway – name: 5 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands |
| Author_xml | – sequence: 1 givenname: Inger Lise surname: Gade fullname: Gade, Inger Lise organization: Department of Clinical Medicine, Aalborg University – sequence: 2 givenname: Sigrid K. surname: Brækkan fullname: Brækkan, Sigrid K. organization: Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway – sequence: 3 givenname: Inger Anne surname: Næss fullname: Næss, Inger Anne organization: Department of Haematology, Trondheim University Hospital, Trondheim, Norway – sequence: 4 givenname: John-Bjarne surname: Hansen fullname: Hansen, John-Bjarne organization: Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway – sequence: 5 givenname: Suzanne C. surname: Cannegieter fullname: Cannegieter, Suzanne C. organization: Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 6 givenname: Frits R. surname: Rosendaal fullname: Rosendaal, Frits R. organization: Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands – sequence: 7 givenname: Kim surname: Overvad fullname: Overvad, Kim organization: Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark – sequence: 8 givenname: Kristian surname: Hindberg fullname: Hindberg, Kristian organization: Department of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø—The Arctic University of Norway, Tromsø, Norway – sequence: 9 givenname: Jens surname: Hammerstrøm fullname: Hammerstrøm, Jens organization: Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway – sequence: 10 givenname: Olga V. surname: Gran fullname: Gran, Olga V. organization: Department of Clinical Medicine, K.G Jebsen Thrombosis Research and Expertise Centre (TREC), University of Tromsø—The Arctic University of Norway, Tromsø, Norway – sequence: 11 givenname: Anne surname: Tjønneland fullname: Tjønneland, Anne organization: Department of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark – sequence: 12 givenname: Marianne T. surname: Severinsen fullname: Severinsen, Marianne T. organization: Department of Haematology, Aalborg University Hospital, Aalborg, Denmark – sequence: 13 givenname: Søren R. surname: Kristensen fullname: Kristensen, Søren R. organization: Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31249936$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1UktvEzEQXqEiWkqvHGGPXLb4vTYHpCriUSkSBwJXy_aOE0e7drE3lfj3OCRBLVIPlq2Z7zHjmZfNWUwRmuY1RtcYcf6-dAhR2WHBsOjls-aCcEw6xQQ_e_A-b65K2SKEsMKCEPWiOaeYMKWouGj8MsV1t4I8tbfRhQGigzb59ifEtCvtapPTZBPUM4YytSG2C1Mh-UNNQfvdmTiEaO6DiSdsCaWt0SOuXaRNyvOr5rk3Y4Gr433Z_Pj8abX42i2_fbld3Cw7R8W-Ew7UIsWoJxghqTjqkbVGEW4H4ylXIASRgvei7w3BgDhmw4AGi5FQsmf0srk96A7JbPVdDpPJv3UyQf8NpLzWJs_BjaCJ8713ZMBIOgbKWk-V9VZ67HqGh75qfTxo3e3sBIODOGczPhJ9nIlho9fpXgtOmBSyCrw9CLgcyhyijikbXRujvcZMMVUR744WOf3aQZn1FIqDcTQR6vdrQjgShBJJKvTNw2r-lXEaZQWwk1sqJYPXLsxmDmlfXBirr94vjS56vzT6uDSVdv0f7aT8JKE7EOZNgAn0Nu1yrDN9Cv8H_DLOrQ |
| CitedBy_id | crossref_primary_10_2147_CLEP_S247823 crossref_primary_10_1055_a_2495_1350 crossref_primary_10_1210_clinem_dgaa501 crossref_primary_10_1016_j_critrevonc_2022_103782 |
| ContentType | Journal Article |
| Copyright | info:eu-repo/semantics/openAccess |
| Copyright_xml | – notice: info:eu-repo/semantics/openAccess |
| DBID | 0U6 AAYXX CITATION NPM 7X8 3HK 5PM DOA |
| DOI | 10.1055/s-0038-1641678 |
| DatabaseName | Thieme Connect Journals Open Access CrossRef PubMed MEDLINE - Academic NORA - Norwegian Open Research Archives PubMed Central (Full Participant titles) DOAJ (Directory of Open Access Journals) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: 0U6 name: Thieme Connect Journals Open Access url: http://open.thieme.com sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2512-9465 |
| EndPage | e138 |
| ExternalDocumentID | oai_doaj_org_article_2cf7fc2d108c4e9bbf39bfb8f1c741d7 PMC6524868 10037_14949 31249936 10_1055_s_0038_1641678 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 0U6 53G AAFWJ ACGFS ADBBV AFPKN AHRAW ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV EBS EJD GROUPED_DOAJ H13 HYE M~E O9- OK1 PGMZT RPM RTC AAYXX APFFQ CITATION NPM 7X8 3HK 5PM |
| ID | FETCH-LOGICAL-c3638-15e3b0943f2100895070bba925bdaf359e6628657677a21e0514dd0db10698743 |
| IEDL.DBID | DOA |
| ISSN | 2512-9465 2567-3459 |
| IngestDate | Wed Aug 27 01:26:24 EDT 2025 Thu Aug 21 18:36:25 EDT 2025 Sat Apr 29 05:42:12 EDT 2023 Fri Jul 11 02:09:38 EDT 2025 Wed Feb 19 02:32:17 EST 2025 Thu Apr 24 22:56:18 EDT 2025 Tue Jul 01 02:36:08 EDT 2025 Sun Nov 24 14:59:14 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | epidemiology cancer time factors venous thromboembolism prospective studies |
| Language | English |
| License | CC BY 4.0 https://creativecommons.org/licenses/by/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3638-15e3b0943f2100895070bba925bdaf359e6628657677a21e0514dd0db10698743 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 TH Open |
| OpenAccessLink | https://doaj.org/article/2cf7fc2d108c4e9bbf39bfb8f1c741d7 |
| PMID | 31249936 |
| PQID | 2250623282 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_2cf7fc2d108c4e9bbf39bfb8f1c741d7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6524868 cristin_nora_10037_14949 proquest_miscellaneous_2250623282 pubmed_primary_31249936 crossref_citationtrail_10_1055_s_0038_1641678 crossref_primary_10_1055_s_0038_1641678 thieme_journals_10_1055_s_0038_1641678 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20180400 |
| PublicationDateYYYYMMDD | 2018-04-01 |
| PublicationDate_xml | – month: 04 year: 2018 text: 20180400 |
| PublicationDecade | 2010 |
| PublicationPlace | Stuttgart · New York |
| PublicationPlace_xml | – name: Stuttgart · New York – name: Germany |
| PublicationTitle | TH open : companion journal to thrombosis and haemostasis |
| PublicationTitleAlternate | TH Open |
| PublicationYear | 2018 |
| Publisher | Georg Thieme Verlag KG |
| Publisher_xml | – name: Georg Thieme Verlag KG |
| SSID | ssj0001916229 |
| Score | 2.027047 |
| Snippet | Abstract
The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and... The risk of venous thromboembolism (VTE) in patients who survive the first years after a cancer diagnosis after the acute effects of disease and treatment in... |
| SourceID | doaj pubmedcentral cristin proquest pubmed crossref thieme |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e131 |
| SubjectTerms | cancer Clinical medical disciplines: 750 epidemiology Health sciences: 800 Helsefag: 800 Klinisk medisinske fag: 750 Medical disciplines: 700 Medisinske Fag: 700 Oncology: 762 Onkologi: 762 Original Original Article prospective studies time factors VDP venous thromboembolism |
| SummonAdditionalLinks | – databaseName: Thieme Connect Journals Open Access dbid: 0U6 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELagIMQF8W54yUgIThGJHdsxN1hRVYhyYRf1ZsUvNlLXQZttfz9jx7tlKZU45GJPlNgzY3_jsT8j9IY5IaTREJZoa2KAQkspDCmdbitNTV13JB5OPvnGjxfNl1N2erne8XcGn7H3YxmzVyXA-hoG1pvoFoFZLtpyteCXqymAcgiRW1bGK68BujXJacLe_JNo-v-FLa9ukby9WfZu5f6YfI7uo3sZNeKPk5ofoBsuPER3TnJe_BHyX4fws5zDKIvB4ad7QvHg8Y_EwIrny_Ww0oOD56wfV7gPeBa1vf4AVQ5_N-lsS3cBprKVHfsRQ2mWw7NhCTj9MVocfZ7Pjst8g0JpKI-tZ47quHfQk0jiIwH8VVp3kjBtO0-ZdDwdTRVciI7ULpKhW1tZDYGibAFcPEEHYQjuEGEvQH0dF7ryrnGua10jhbVcchL9mBToMPewCmC8kQuZCggsZCMLVG67XJnMPB4vwDhTKQPOmBojRWmrsrIK9G4n_2vi3LhW8lPU4E4qcmWnAjAglV1PEeOFN8TWVWsaJ7X2VGqvW18bgFNWFOj1Vv8KfCsmTLrgQDsKxroK4CFEpQV6OtnD7lM03totKS-Q2LOUvX_Zrwn9MvF3c0aalsPPv51sSuVhY7ymlc_-V_A5ugt4rp02Fr1AB5v1uXsJmGmjXyV3-Q2IBg1u priority: 102 providerName: Thieme |
| Title | Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort |
| URI | http://dx.doi.org/10.1055/s-0038-1641678 https://www.ncbi.nlm.nih.gov/pubmed/31249936 https://www.proquest.com/docview/2250623282 http://hdl.handle.net/10037/14949 https://pubmed.ncbi.nlm.nih.gov/PMC6524868 https://doaj.org/article/2cf7fc2d108c4e9bbf39bfb8f1c741d7 |
| Volume | 2 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZgBYgL4r3hsTISglO0iRPbMTeoWK0Qy4UW7c2KXzTS1kFN4fcz46RVK1hx4ZCLM1Jsz2f7m9j-hpDX3EuprIGwxDiLAUqVK2lZ7k1TmMqWZcvwcvLFF3G-qD9d8su9VF94JmyUBx477pTZIINlriwaW3tlTKiUCaYJpYXF0KV75IUq9oKp9HcFWA9LKcpw_cY88nyr2Mj56ZDjhlgOkUIpML_abZsGVDxYm5KE_99455_HJ29tlp1f-b2F6ew-uTcxSvp-bMkDcsPHh-TOxbRn_oiEz338ns9hBqYwGYw5RGkf6Lekzkrny3W_Mr2H56obVrSLdIZIWL-DV55-teneS_sLYLS1HbqBQulkR2f9Ejj8Y7I4-zifnedTdoXcVgJbz31l8FxhYCjwo4AYFsa0inHj2lBx5UW6tiqFlC0rPQqlO1c4A0GkaoB4PCFHsY_-mNAgwbWtkKYIvva-bXytpHNCCYZjnGXkeOphHQHYqJNcSQg6VK0ykm-7XNtJlRyTY1zptDvOuR5QvrTRk7My8nZn_2PU47jW8gN6cGeFOtqpANClJ3Tpf6ErI6-2_tcw7nAzpY0evKNhHiyAOkLEmpGnIx52n6owo7eqREbkAVIO6nL4JnbLpO0tOKsbAZV_M2JKT1PKcE0rn_2PVj4nd4EHNuOBpBfkaLP-6V8C19qYE3KzWIiTNLh-A1gNI4k |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dj5QwEG_0NOqL8es8_KyJ0SeyUKClvunGy6q79-KuubeGlvbYZBcuC_r3OwNldXNe4gMvMITSmSm_oTO_IeRtZoWQRkNYokuDAUoSSmFYaHUe6cTEccGwOHlxxmer9Ot5du7Lo1ufVtlVa7u1ocFMD9NhqsXlwH7aTqyf4XZSdduN71ObTdoQd7hCgP4xLL43yS0smEQm_WjF__xxASTEmByZG6_cBgjY9I5VH3yjeir_f-HPq2mUt4eR__WBOn1A7ntkST8OpvCQ3LD1I3Jn4ffOHxM3b-qLcAkrMYVFYeglShtHf_QsrXRZ7Zqtbiwcm3W7peuaTtEidh_gkqXfTV__UvwCcxpl23VL4ayXo9OmAiz_hKxOPy-ns9B3WQhNwvHtM5tozC90DIl-JADESOtCskyXhUsyaXlfviq4EAWLLRKml2VUaggmZQ4A5Jgc1U1tTwh1AlRccKEjZ1Nri9ymUpQll5yhr7OAnPgZVjUYOPIlJwKCD5nKgITjlCvj2cmxScZG9bvkWaZapDHNlVdWQN7v5S8HXo5rJT-hBvdSyKfdn2h2F8q7p2LGCWdYGUe5Sa3U2iVSO5272ADkKkVA3oz6V-B_uKlS1Ba0o2A9jABCQuQakKeDPewflWBnb5nwgIgDSzkYy-GVel31HN88Y2nOYfDvBptSo-Ff85bP_lfwNbk7Wy7mav7l7Ntzcg_wXz4kIr0gR93up30JGKvTr3rX-Q3-Gx7Z |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED-NgSZeEN8Ln0ZC8BSaOIkd8waFasA2kGjR3qzYsddKa1I1hb-fs-MUqjGJh7zEV8Xx3Tm_q-9-B_CyMJwLrTAsUbV2AUoWC65pbFSZqEynaUVdcfLJKTua5Z_PirM9-DrUwri0ys18YZYm1i7TQ29cqsWqZz_tRiascDda1Ta0qS1GXewOuGJE_inuvW9w6Bpc90XeaODJjP350wXBEKViIG-89FMEwdr7VrPzmfJs_v-CoJczKW_0k__rGzW5DbcCuCTvemu4A3umuQsHJ-H4_B7Y47Y5j6e4GRPcF_p2oqS15IcnaiXT-bpdqtbgdbHolmTRkLEzivVbHDLku_YlMNUvtKhBtlt0BO8GOTJu5wjn78Ns8nE6PopDo4VYZ8y9fWEy5VIMLXVcPwIxYqJUJWih6spmhTDMV7ByxnlFU-M40-s6qRXGk6JEDPIA9pu2MYdALEctV4yrxJrcmKo0ueB1zQSjzt1pBIdhhWWDNu4okzOO8YfIRQTxsORSB4Jy1yfjQvqD8qKQnWMyLWVQVgSvt_KrnprjSsn3ToNbKUep7W-063MZPFRSbbnVtE6TUudGKGUzoawqbaoRddU8gheD_iW6oDtXqRqD2pG4JSaIIjF4jeBhbw_bR2WuubfIWAR8x1J25rI70izmnuabFTQvGU7-VW9TcrD9K97y0f8KPoeDbx8m8vjT6ZfHcBMRYNmnIj2B_c36p3mKKGujnnnP-Q1YQh9s |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-Term+Incidence+of+Venous+Thromboembolism+in+Cancer%3A+The+Scandinavian+Thrombosis+and+Cancer+Cohort&rft.jtitle=TH+open+%3A+companion+journal+to+thrombosis+and+haemostasis&rft.au=Gade%2C+Inger+Lise&rft.au=Br%C3%A6kkan%2C+Sigrid+K.&rft.au=N%C3%A6ss%2C+Inger+Anne&rft.au=Hansen%2C+John-Bjarne&rft.date=2018-04-01&rft.pub=Georg+Thieme+Verlag+KG&rft.issn=2567-3459&rft.eissn=2512-9465&rft.volume=2&rft.issue=2&rft.spage=e131&rft.epage=e138&rft_id=info:doi/10.1055%2Fs-0038-1641678&rft_id=info%3Apmid%2F31249936&rft.externalDocID=PMC6524868 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2512-9465&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2512-9465&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2512-9465&client=summon |